BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Search i

Search help

  • Enter one or more search terms in the search field. Upper and lower case are not relevant.
  • As soon as you have entered three letters in the search field, various search words will be suggested from which you can choose one.
  • If you are searching for a certain group of words, put these words in double quotes. The hits will then contain the words in the order you entered, e.g. "medicines for children".
  • Multiple search terms can also be combined with the Boolean operators AND and OR. When using the operator AND, the results contain the intersection of all search terms. When using the operator OR, the hits contain one of the search terms or only individual search terms. The result set is therefore significantly larger. Please note that these operators must be written in capital letters.
  • If you receive a (too) large number of hits as a result of your search, you can narrow it down by using filters. These filter options appear to the left of the search results and are subdivided into:

    • category (e.g. safety of medicinal products, medical devices, code systems)
    • format (e.g. download, risk information, DHPCs)
    • time interval (e.g. last 30 days, older than ...)
  • Selected filters can be removed individually or all at once ("Show all results").
  • By default, search results are sorted by relevance, but they can also be sorted chronologically ("Latest entries first" or "Oldest entries first").

Enter search term

6 results

Results per page: 10 20 30

Selected filter

Photos Date: 26. January 2024 Topics: Presse Type: Article

The images may be used free of cost as part of editorial reporting subject to acknowledgement of the source. Use for advertising or for commercial purposes is prohibited.

Information on individual healing attempts at COVID-19 with hydroxychloroquine PDF, 265KB, File is accessible Date: 25. March 2020 Topics: Presse Type: Download

Information on individual healing attempts at COVID-19 with hydroxychloroquine

Dear Doctor Letter (Rote-Hand-Brief) on Xalkori® (crizotinib): New recommendations regarding the risk of cardiac insufficiency PDF, 224KB, File is accessible Date: 14. October 2015 Topics: Presse Type: Direct Healthcare Professional Communication

Active substance: crizotinib

The company Pfizer Pharma GmbH is circulating information that severe, sometimes lethal, cases of cardiac insufficiency have been reported in patients with ALK-positive NSCLC treated with crizotinib.

BfArM and Swissmedic sign an agreement on closer collaboration Date: 13. January 2014 Topics: Presse Type: Press release

The German Federal Institute for Drugs and Medical Devices (BfArM) and Swissmedic, the Swiss Agency for Therapeutic Products, have agreed to work together more closely in the area of therapeutic products.

Dear Doctor Letter (Rote-Hand-Brief) on Gilenya® (fingolimod): Update on the recommendation for cardiovascular monitoring at the beginning of treatment PDF, 352KB, File is accessible Date: 30. April 2012 Topics: Presse Type: Direct Healthcare Professional Communication

Active substance: fingolimod

Important additional recommendations regarding a more intense monitoring of cardiovascular functions at the beginning of treatment with Gilenya® (fingolimod) in patients with relapsing-remitting multiple sclerosis.

Medicinal properties of skin and hand disinfectants for human use Date: 09. October 2009 Topics: Presse Type: Press release

According to the German Medicines Act (AMG) – also since the 15th Amendment of July17th 2009 – skin antiseptics and hand disinfectants are medicinal products, ....